Tejnaksh Healthcare Ltd vs Vanta Bioscience Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 29, 2026

Key Highlights

The Latest Trading Price of Tejnaksh Healthcare Ltd is ₹ 12.36 as of 29 Oct 15:30 . The P/E Ratio of Tejnaksh Healthcare Ltd changed from 36 on March 2021 to 19.9 on March 2026 . This represents a CAGR of -9.41% over 6 yearsThe P/E Ratio of Vanta Bioscience Ltd changed from 229.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Tejnaksh Healthcare Ltd changed from ₹ 73.94 crore on March 2021 to ₹ 24.23 crore on March 2026 . This represents a CAGR of -16.97% over 6 yearsThe Market Cap of Vanta Bioscience Ltd changed from ₹ 102.89 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Tejnaksh Healthcare Ltd for the Jun '26 is ₹ 2.75 crore as compare to the Mar '26 revenue of ₹ 2.69 crore. This represent the growth of 2.23% The revenue of Vanta Bioscience Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Tejnaksh Healthcare Ltd for the Jun '26 is ₹ 0.79 crore as compare to the Mar '26 ebitda of ₹ 0.85 crore. This represent the decline of -7.06% The ebitda of Vanta Bioscience Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Tejnaksh Healthcare Ltd changed from ₹ 0.6 crore to ₹ 0.26 crore over 9 quarters. This represents a CAGR of -31.04% The net profit of Vanta Bioscience Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Tejnaksh Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Vanta Bioscience Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Tejnaksh Healthcare Ltd

Tejnaksh Healthcare Limited was incorporated in Mumbai on 18 February, 2008 as a Private Limited Company and converted into Public Limited Company with effect from 10 March, 2015 issued by the Registrar of Companies, Mumbai, Maharashtra.
Tejnaksh runs an Institute of Urology, an ISO certified the international level Urology hospital, located in Dhule, Maharashtra.
It provides a complete range of services from consultations and investigations to treatment for Urology.
The main objective of Hospital namely Institute of Urology is to provide the people of Khandesh region of Maharashtra, the services of a super specialty hospital at an affordable rate. Initiated with a vision to strengthen healthcare in rural India, the Company started its journey from Institute of Urology, a state of the art flagship, kidney care center in Dhule in the year 2003.

About Vanta Bioscience Ltd

Vanta Bioscience Limited (VBS) was originally incorporated as a Private Limited Company on 29th April 2016 and was converted into a Public Limited Company with effect from 17th March 2017. VBS is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.
In addition, Company provide risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product.
It also provides expert services for determination of health based exposure limits (e.

FAQs for the comparison of Tejnaksh Healthcare Ltd and Vanta Bioscience Ltd

Which company has a larger market capitalization, Tejnaksh Healthcare Ltd or Vanta Bioscience Ltd?

Market cap of Tejnaksh Healthcare Ltd is 25 Cr while Market cap of Vanta Bioscience Ltd is 14 Cr

What are the key factors driving the stock performance of Tejnaksh Healthcare Ltd and Vanta Bioscience Ltd?

The stock performance of Tejnaksh Healthcare Ltd and Vanta Bioscience Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Tejnaksh Healthcare Ltd and Vanta Bioscience Ltd?

As of October 29, 2026, the Tejnaksh Healthcare Ltd stock price is INR ₹12.36. On the other hand, Vanta Bioscience Ltd stock price is INR ₹20.4.

How do dividend payouts of Tejnaksh Healthcare Ltd and Vanta Bioscience Ltd compare?

To compare the dividend payouts of Tejnaksh Healthcare Ltd and Vanta Bioscience Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.